on Anaesthesiology, Intensive Therapy and Pain Medicine

Mervyn Singer

Topics on the BUS-13: 

  • Is COVID sepsis?

Professor Mervyn Singer MB BS MD FRCP(Lon) FRCP(Edin) FFICM, Professor of Intensive Care Medicine, Director of Centre for Intensive Care Medicine, Department of Medicine & Wolfson Institute for Biomedical Research, University College London, UK

His primary research interests are sepsis and multi-organ failure, infection, shock and haemodynamic monitoring. Funding for these activities primarily comes from the Wellcome Trust, Medical Research Council and National Institute for Health Research.

He developed an oesophageal Doppler haemodynamic monitor that is now in widespread use worldwide, the use of which has been shown in multiple studies to improve outcomes after major surgery and reduce length of stay. He has led on a number of important multi-centre trials in critical care.

Professor Singer has authored various papers and textbooks including the Oxford Handbook of Critical Care, now in its 3rd Edition, and is a Council member of the International Sepsis Forum.

Professor Singer was the first UK intensivist to be awarded Senior Investigator status by the National Institute for Health Research, and to be invited to give plenary lectures at the European and US Intensive Care Congresses.

Prof. Mervyn Singer participated in BUS-4 (2012):

  • Management of the critical ill – is less sometimes more? What does history teach us.
  • Are antibiotics life-saving? A proven panacea or persuasive propaganda.


See all Faculty